Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy

AIEOP (Italian Association of Pediatric Hematology, Oncology) Italian Group of Pediatric Surgical Oncology, Pediatric Hodgkin’s Lymphoma working Group, Roberta Burnelli, Simona Rinieri, Roberto Rondelli, Alessandra Todesco, Maurizio Bianchi, Alberto Garaventa, Marco Zecca, Paolo Indolfi, Valentino Conter, Nicola Santoro, Maurizio Aricò, Simone Cesaro, Salvatore D'amico, Piero Farruggia, Raffaela De Santis, Franco Locatelli, Stefano A PileriGiovanni Scarzello, Maurizio Mascarin, Vico Vecchi

Research output: Contribution to journalArticle

Abstract

Identify a subset of early-stage HL children (GR1) curable with limited chemotherapy+/-radiotherapy; improve outcome of intermediate (GR2) and high-risk (GR3) patients; establish impact of response to chemotherapy evaluated with conventional imaging (CI). One hundred and sixty GR1-patients received 3ABVD + involved-field (IF) low-dose (LD) (20 Gy) irradiation if mediastinal mass or partial response (PR) after chemotherapy. Eighty-five GR2- and 315 GR3-patients received 4 and 6 COPP/ABV + IFRT, respectively. The 63 GR1 patients spared from radiotherapy had 15-year survival and EFS of 100 and 84.5%, respectively. The GR2 and GR3 15-year FFP were 84.7 and 78.6%, respectively. No different prognosis for patients in CR or PR evaluated during and after chemotherapy was observed. In conclusion, low-risk patients in CR may be successfully treated with radiation-free, low-intensity chemotherapy. Good, but less satisfactory, results were registered in GR2 and GR3. Response evaluated with CI is not a prognostic factor, but permits identification of low-risk patients who can avoid radiotherapy.
Original languageEnglish
Pages (from-to)2612-2621
Number of pages10
JournalLeukemia and Lymphoma
Volume59
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint Dive into the research topics of 'Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy'. Together they form a unique fingerprint.

  • Cite this

    Hematology, AIEOP. I. A. O. P., Italian Group of Pediatric Surgical Oncology, O., Group, P. H. L. W., Burnelli, R., Rinieri, S., Rondelli, R., Todesco, A., Bianchi, M., Garaventa, A., Zecca, M., Indolfi, P., Conter, V., Santoro, N., Aricò, M., Cesaro, S., D'amico, S., Farruggia, P., De Santis, R., Locatelli, F., ... Vecchi, V. (2018). Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy. Leukemia and Lymphoma, 59(11), 2612-2621. https://doi.org/10.1080/10428194.2018.1435872